3-MeO-PCE (3-Methoxyeticyclidine) is a dissociative arylcyclohexylamine that acts primarily as an NMDA receptor antagonist. It disrupts normal neuronal signaling in a way that induces detachment from the physical environment, altered perception, and modified thought patterns. While chemically similar to PCP and ketamine, 3-MeO-PCE has its own unique pharmacological profile, often producing both dissociative and mildly stimulating effects. It is commonly used in research to study the mechanisms of consciousness, perception, and neuroplasticity.

• NMDA Receptor Antagonist
  3-MeO-PCE blocks NMDA receptors in the brain, interrupting glutamate transmission, which is essential for memory formation, cognition, and perception. This leads to the “dissociative” experience observed in test subjects and models.

• Arylcyclohexylamine Structure
  It belongs to the same chemical family as PCP and ketamine, but with modifications that give it a more balanced profile between stimulation and dissociation.

• Functional Dissociation
  Unlike some dissociatives that produce heavy sedation, 3-MeO-PCE often allows test subjects (in lab simulations) to remain cognitively active while experiencing detachment from body or environment.

• Low to Moderate Hallucinogenic Potential
  Visual distortions and altered sensory input may occur at high doses, but 3-MeO-PCE is generally less visually hallucinogenic than classic psychedelics like LSD or DMT.

• Stimulatory Edge
  Reports and studies indicate a mild stimulating quality compared to more sedating dissociatives. This has implications for its unique interaction with brain regions tied to motivation and movement.

• Prolonged Mental Effects
  Mental effects such as enhanced introspection or cognitive shifts may persist for hours after physical effects wear off, making it of particular interest in consciousness research.

The legality of 3-MeO-PCE is jurisdiction-dependent. While it is unscheduled and legally obtainable for research in some countries, others have placed it under analog laws or specific bans. Psycho Plug sells 3-MeO-PCE strictly for laboratory and research purposes, and we strongly advise all customers to understand their local laws before ordering.

• Legally Unscheduled in Some Countries
  In nations like Canada and parts of Europe, 3-MeO-PCE may not be specifically scheduled, allowing for legal research-based possession and purchase.

• Controlled Substance in Other Regions
  Countries including the United Kingdom, Sweden, and Australia list 3-MeO-PCE as a controlled substance, making possession or importation illegal without a license.

• Analog Laws May Apply
  In the United States, 3-MeO-PCE may be subject to the Federal Analogue Act if intended for human consumption, even if it’s not specifically scheduled.

• For Research Use Only
  All sales from Psycho Plug are under the condition that the product will be used exclusively for non-human research in controlled laboratory settings.

• Discreet Shipping Minimizes Risk
  Our packaging and documentation are designed to protect your privacy and avoid unnecessary legal complications during transit.

• Responsibility Lies with the Buyer
  We cannot provide legal advice, and it is ultimately the buyer’s responsibility to verify whether 3-MeO-PCE can be lawfully imported and possessed in their region.

Though structurally similar, 3-MeO-PCE and 3-MeO-PCP differ significantly in terms of potency, duration, and subjective research effects. Understanding these differences is crucial when selecting the appropriate compound for a given research objective.

• Molecular Difference
  3-MeO-PCE contains an ethyl group, while 3-MeO-PCP has a propyl group. This slight structural change influences receptor binding affinity and pharmacokinetics.

• Potency
  3-MeO-PCP is generally more potent by weight than 3-MeO-PCE, requiring smaller dosages to produce comparable dissociative effects in simulations.

• Duration
  3-MeO-PCP typically has a longer effect window (6–10 hours), while 3-MeO-PCE is more manageable with a 4–8 hour duration, allowing more flexible study sessions.

• Cognitive Clarity vs. Disorientation
  3-MeO-PCE is often considered more “functional,” allowing for clearer thought processes during the dissociative experience compared to the more mentally foggy or overwhelming effects of 3-MeO-PCP.

• Emotional Tone
  Anecdotal and observational reports suggest 3-MeO-PCE carries a more empathogenic and emotionally neutral profile, whereas 3-MeO-PCP can lean toward emotional blunting or detachment.

• Motor Control
  3-MeO-PCP is more likely to induce ataxia or significant motor disruption. 3-MeO-PCE retains more movement coordination, making it suitable for cognitive-motor experiments.

• Application Suitability
  Researchers seeking subtle dissociation and insight often favor 3-MeO-PCE, while those exploring high-potency models of psychosis or trauma states may lean toward 3-MeO-PCP.

The typical effects of 3-MeO-PCE include dissociation, mental stimulation, mild euphoria, and altered perception of time and space. These effects can be highly dose-dependent and vary by individual or animal model in lab settings. Unlike more sedative dissociatives, 3-MeO-PCE often produces a clearer and more “awake” state of altered consciousness.

• Cognitive Dissociation
  Detachment from thoughts, memories, or identity without full unconsciousness—useful in experiments related to cognitive partitioning.

• Mild Euphoria
  At lower doses, some models report emotional warmth and positive affective changes, potentially linked to dopamine and serotonin modulation.

• Temporal Distortion
  A common effect in lab simulations, where time appears to slow down or become non-linear, valuable for temporal cognition research.

• Enhanced Focus or Internal Thought
  Despite dissociation, 3-MeO-PCE can induce a paradoxical mental clarity, often compared to meditative or introspective states.

• Perceptual Changes
  Objects may appear warped, sound may be delayed or echoed, and proprioception (awareness of body in space) may shift, offering insight into sensory integration.

• Physical Lightness or Disembodiment
  A feeling of floating or being outside one’s body is often reported, consistent with the mechanism of NMDA antagonism in sensory pathways.

• Residual Stimulation
  Some users report lingering mental activation or difficulty sleeping for several hours post-use, which should be considered when planning extended research windows.

When handled with proper care, dosage control, and laboratory standards, 3-MeO-PCE is considered suitable for research. However, its dissociative properties require that all handling be conducted in a strictly controlled environment, as the margin between effective and excessive dosages is narrow.

• High-Purity Formulation Required
  Only verified, laboratory-tested samples with confirmed purity should be used to avoid impurities or adulterants that may skew research results or increase risk.

• Accurate Dosing Instruments Essential
  Milligram-precision scales or volumetric dosing techniques are necessary to prevent accidental overdoses in testing.

• Proper Storage Maintains Stability
  Compound should be stored in an airtight, light-proof container in a cool, dry place to maintain chemical stability for long-term experiments.

• Protective Gear Recommended
  Use of gloves, eye protection, and fume hoods is advised during handling to avoid accidental contact or inhalation.

• Human Use is Prohibited
  This compound is sold strictly for in-vitro or in-vivo non-human research and should never be consumed.

• Clear Documentation and Batch Tracking
  Researchers should label and log all 3-MeO-PCE batches with dates, purity certificates, and experiment logs for traceability.

Storing 3-MeO-PCE correctly is crucial to preserving its chemical integrity, potency, and reliability for future research use. As with all arylcyclohexylamines, environmental factors such as light, air, moisture, and temperature can degrade the compound over time. Following best practices ensures stability and reduces the risk of contamination or degradation.

• Store in a Cool Environment
  Ideal temperature range is between 2°C and 8°C (35°F to 46°F). Avoid exposure to heat sources or direct sunlight, which can alter molecular structure.

• Use an Airtight, Sealed Container
  Keep 3-MeO-PCE in vacuum-sealed or airtight jars to prevent exposure to air and moisture. Oxygen and humidity accelerate degradation and reduce shelf life.

• Protect from Light
  Light-sensitive compounds like 3-MeO-PCE should be kept in dark glass containers or opaque storage solutions to avoid UV-induced breakdown.

• Avoid Frequent Handling
  Repeatedly opening the container increases air and humidity exposure. Portioning your supply into smaller containers for daily use can help preserve the bulk stock.

• Label with Batch & Date
  Always record the batch number, purity percentage, and date of receipt to track chemical viability over time and maintain experimental consistency.

• Keep Out of Reach
  For safety, store securely away from unauthorized individuals, pets, or children. A lockable cabinet is ideal in shared lab or home settings.

Psycho Plug supplies 3-MeO-PCE in its most stable and research-appropriate form: high-purity crystalline powder. This format is preferred for its ease of measurement, rapid solubility in solvents, and long shelf life under proper storage conditions. Understanding its physical characteristics helps researchers plan appropriate protocols.

• Crystalline Powder Form
  The compound appears as a fine, white to off-white powder with minimal odor. It is dry, granular, and not hygroscopic under typical lab conditions.

• Highly Soluble in Select Solvents
  It dissolves in ethanol, acetone, and DMSO for in-vitro testing. Water solubility is limited and should be evaluated carefully for each research application.

• Batch-Tested for Uniformity
  We provide consistent particle size and chemical composition across batches to ensure repeatable experimental outcomes.

• Not Available in Capsules or Liquids
  We do not formulate 3-MeO-PCE in capsules, pills, or solutions. Researchers must handle raw powder using proper tools and dilution techniques.

• Labeled and Sealed
  Each unit is labeled with the compound name, weight, purity, and storage instructions, vacuum-sealed for maximum shelf stability.

3-MeO-PCE has become an increasingly valuable compound in pharmacological, behavioral, and neurocognitive research. Its NMDA antagonistic properties make it useful for studying dissociative states, memory interruption, and consciousness models in both human and non-human systems—always under strictly controlled, ethical research environments.

• Neuropharmacology Studies
  Researchers study its effects on the glutamatergic system, especially the NMDA receptor, which plays a key role in synaptic plasticity and memory encoding.

• Cognitive Disruption Models
  Used in behavioral simulations to evaluate how dissociative agents impact logic, time perception, and environmental awareness.

• Consciousness Exploration
  Helps researchers simulate and explore non-ordinary states of consciousness, useful in philosophy of mind, dream research, and psychedelic neuroscience.

• Comparative Chemical Profiling
  As a close analog to PCP and ketamine, 3-MeO-PCE is valuable for cross-comparison studies to differentiate the effects of structural modifications.

• Dose-Response Analysis
  Studies involve evaluating the relationship between dosage levels and specific behavioral or physiological outcomes over time.

• Toxicity & Interaction Research
  Researchers assess thresholds for neurotoxicity, organ load, or how the compound interacts with other receptor systems and pharmaceuticals.

Improper handling, measurement, or unauthorized human use of 3-MeO-PCE poses serious health, legal, and research risks. Its dissociative effects can lead to confusion, psychosis-like behavior, or physical danger in uncontrolled settings. Psycho Plug supplies this product strictly for laboratory use and never for human consumption.

• Overdose Potential
  Small miscalculations can lead to significantly stronger effects. Overdoses have been associated with seizures, psychotic breaks, and loss of consciousness.

• Psychological Effects
  In high doses, or when used inappropriately, it may induce paranoia, delusional thinking, or severe anxiety—all of which can derail research or harm test subjects.

• Motor Coordination Loss
  Impaired balance and slowed reflexes increase the risk of accidents. Uncontrolled studies or misuse pose physical safety hazards.

• Unknown Long-Term Health Effects
  Chronic use or exposure is poorly studied. Potential for neurotoxicity, cognitive decline, or dependency cannot be ruled out without long-term data.

• Contamination Risks
  Using unverified sources or mishandling the product (e.g., with dirty tools) may introduce unknown chemicals into experiments.

• Legal Consequences
  In jurisdictions where 3-MeO-PCE is banned or regulated, unauthorized possession or use can result in fines, arrest, or loss of professional licenses.

Standard drug testing panels used in workplaces or basic law enforcement screenings do not usually include 3-MeO-PCE. However, with the rise in designer drugs, specialized testing methods are becoming more common. The likelihood of detection depends on the type of test used and whether it’s designed to identify arylcyclohexylamines or their metabolites.

• Not Included in Standard 5-Panel Tests
  Basic urine drug screens (for THC, cocaine, opiates, amphetamines, and PCP) typically do not detect 3-MeO-PCE or its analogs.

• Possible Detection in Advanced Panels
  Extended or customized panels (e.g., 10–14 panel screens) may detect dissociatives similar to PCP and could cross-react depending on the technology.

• GC-MS and LC-MS Capable
  Gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS) can detect trace amounts if specifically calibrated for 3-MeO-PCE metabolites.

• Detection Window Unknown
  Because long-term pharmacokinetic data is limited, it is unclear how long 3-MeO-PCE remains detectable in urine, blood, or hair.

• Not Routinely Searched
  Unless there is suspicion of research chemical usage, most employers or clinics do not screen for arylcyclohexylamines.

• Legal Context Still Applies
  In regions where 3-MeO-PCE is illegal, detection—even in small research settings—can result in legal repercussions regardless of intent.

Accurate measurement of 3-MeO-PCE is crucial for ensuring consistency, safety, and reliability in laboratory settings. Due to its high potency and low effective dosage range, even minor measurement errors can result in significantly different outcomes. Researchers must use professional tools and adopt meticulous handling protocols to ensure data integrity and minimize risk.

• Use a Precision Milligram Scale
  A digital scale accurate to 0.001 grams (1 milligram) is the minimum standard. Consumer-grade kitchen scales are completely unsuitable for this purpose.

• Calibrate Before Each Use
  Scales must be regularly calibrated with known weights to ensure measurement accuracy. This is especially important in environments prone to temperature or surface fluctuations.

• Volumetric Measurement for Microdosing
  Dissolving a known amount of 3-MeO-PCE into a solvent (e.g., ethanol or distilled water) creates a measurable solution for ultra-small quantities. This technique is commonly used in analytical dosing experiments.

• Avoid Estimation or Visual Guesswork
  Visual estimations or “eyeballing” amounts can result in critical errors due to the compound’s fine powder consistency and high potency.

• Use Anti-Static Tools
  Anti-static spatulas or scoops prevent powder from clinging and allow for more consistent transfers, especially in humid environments.

• Separate Measuring Area
  Dedicate a clean, stable area for weighing and avoid cross-contamination with other chemicals or samples. Isolating the weighing process minimizes exposure and error.

Yes, 3-MeO-PCE has the potential to interact dangerously with a variety of substances. While its primary action is as an NMDA receptor antagonist, it may also affect dopamine and serotonin systems. Combining it with other psychoactive or depressant agents can increase the risk of toxicity, adverse reactions, or unpredictable results.

• Alcohol Increases Sedation Risk
  Combining 3-MeO-PCE with alcohol amplifies central nervous system depression, potentially leading to unconsciousness, respiratory depression, or memory blackouts.

• Benzodiazepines May Impair Memory Further
  Co-administration with benzos like diazepam or alprazolam may deepen cognitive suppression and increase the risk of amnesia or coordination loss.

• Stimulants Increase Heart Strain
  When paired with stimulants such as amphetamines or caffeine, users may experience heart palpitations, anxiety, or erratic physiological responses.

• SSRIs or Serotonergic Agents
  Though 3-MeO-PCE is not a direct serotonin agonist, interactions with SSRIs or serotonergic psychedelics could increase the risk of serotonin-related complications in research.

• Other Dissociatives Multiply Effects
  Combining with other NMDA antagonists (like ketamine or DXM) can lead to extreme disorientation, psychosis, or loss of physical awareness.

• Lack of Peer-Reviewed Data
  There is currently limited published research on exact interaction profiles, so combinations should be avoided in all non-clinical studies.

The duration of 3-MeO-PCE’s effects varies based on dosage, method of administration, metabolism, and individual response. In laboratory models, the compound typically demonstrates a moderate duration relative to its class, making it manageable for time-bound research while still allowing for extended observation windows.

• Onset Within 15–45 Minutes
  Effects usually begin within 15 to 45 minutes of administration in test models, depending on variables like form and metabolic rate.

• Peak Effects Around 90–180 Minutes
  Peak intensity generally occurs 1.5 to 3 hours after administration, during which time dissociation and cognitive shifts are most prominent.

• Total Duration Between 4–8 Hours
  The primary window of action typically spans 4 to 8 hours, with functional dissociation tapering off gradually.

• After-Effects May Persist
  Some test subjects report lingering stimulation or mild cognitive changes up to 12 hours post-administration, even after peak effects have ended.

• Dose-Dependent Duration
  Larger doses result in longer effects and slower comedown phases, making accurate dosing essential for time-sensitive experiments.

• Shorter Than 3-MeO-PCP
  Compared to 3-MeO-PCP, which can last 6–10 hours, 3-MeO-PCE provides a shorter and often more predictable duration for research timelines.

The chemical structure of 3-MeO-PCE determines its pharmacodynamics and distinguishes it from other arylcyclohexylamines. A small change in its alkyl side chain—from propyl in PCP to ethyl in PCE—modifies its receptor binding, duration, and effects. Understanding its molecular makeup is essential for researchers conducting receptor studies or structural analog comparisons.

• IUPAC Name
  The full IUPAC designation is N-Ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine, reflecting the compound’s three primary components: methoxyphenyl, cyclohexyl, and ethylamine.

• Molecular Formula
  The molecular formula is C15H23NO, consisting of 15 carbon atoms, 23 hydrogen atoms, one nitrogen, and one oxygen atom.

• Molecular Weight
  The compound weighs 233.35 g/mol, useful in molarity-based solution preparation for volumetric experiments.

• Arylcyclohexylamine Backbone
  Its central cyclohexyl ring attached to a phenyl group places it firmly in the dissociative arylcyclohexylamine class, similar to ketamine and PCP.

• Methoxy Substitution
  The 3-methoxy group on the phenyl ring increases lipophilicity and alters the compound’s interaction with neuroreceptors, particularly NMDA sites.

• Ethyl Side Chain
  The ethyl substitution on the amine group (instead of the propyl in PCP) results in a slightly less potent, more controllable pharmacological profile.

3-MeO-PCE is not considered physically addictive in the traditional sense, but like many dissociatives, it carries a risk for psychological dependency, especially in uncontrolled environments. Researchers studying behavioral reinforcement, redosing patterns, or tolerance development must be aware of its habit-forming tendencies in repeated exposure models.

• Mild Psychological Reinforcement
  Due to its stimulating and dissociative combination, 3-MeO-PCE may encourage redosing in test subjects seeking prolonged effects or novelty.

• No Known Physical Withdrawal
  Unlike opioids or alcohol, cessation of use doesn’t typically produce physical withdrawal symptoms. However, mood instability or cognitive fatigue can follow excessive use.

• Rapid Tolerance Buildup
  Repeated use in short intervals leads to diminished effects, necessitating higher dosages for the same outcome—an important variable in tolerance and dependency research.

• Habitual Use Patterns
  Anecdotal data from independent user reports suggest compulsive use in some individuals, particularly where access is unregulated.

• Not Officially Classified as Addictive
  3-MeO-PCE is not listed as an addictive substance in most clinical classifications, but absence of regulation does not equate to safety.

• Caution for Long-Term Studies
  Repeated dosing in longitudinal models should be carefully designed to avoid confounding behavioral dependencies.